APRISO 375 mg/1
mesalamine · CAPSULE, EXTENDED RELEASE · Salix Pharmaceuticals, Inc.
No Recall History
Plain English
APRISO is a capsule, extended release containing mesalamine at 375 mg/1, taken oral. Manufactured by Salix Pharmaceuticals, Inc..
Key Facts
- Brand Name
- APRISO
- Generic Name
- mesalamine
- NDC Code (Product)
65649-103- Manufacturer
- Salix Pharmaceuticals, Inc.
- Strength
- 375 mg/1
- Dosage Form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA022301
- Drug Class
- Aminosalicylate [EPC]
- Marketing Start
- 10/31/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is APRISO used for?
APRISO contains mesalamine. It is a capsule, extended release taken oral. Consult your doctor for specific uses.
Is APRISO a controlled substance?
APRISO is not classified as a controlled substance by the DEA.
What is the generic name for APRISO?
The generic name for APRISO is mesalamine. There are 12 other brand versions of mesalamine.
What is the NDC code for APRISO 375 mg/1?
The NDC (National Drug Code) for APRISO 375 mg/1 is 65649-103, listed by Salix Pharmaceuticals, Inc..